Detail akcie MusclePharm Corp, Ordinary, US 'Other OTC' and Grey Market online

Top akcie

Název	Návštěvy
Bank of America	26
Silex Systems Depository Receipt	20
Cellectar Bioscn Rg	9
Curaleaf Hldg Rg	9
SBTC/21Shares open	7
EVT/MSI open	9
Mcgrath	13
Talga Resources	25
Air Lease CPP Rg-A	38
iShs MSCI Taiw Indx	3

Moje portfolio

Nastavit Oblíbené, nastavit Portfolio

Oblíbené tituly

select

Název	Nejlepší nákup	Nejlepší prodej	Změna (%)
ČEZ			0,00
KB			0,00
PKN	67,05	67,07	-1,18
Msft			0,37
Nokia	3,4035	3,4105	-0,04
IBM			1,05
Mercedes-Benz Group AG	73,91	73,93	-0,04
PFE			-0,19

25.04.2024 0:03:01

Zpožděná data, Real-Time data info

Indexy online

Další akciové indexy

AD Index online

Region

Výsledková sezóna

03.04.2024 23:20:00

MusclePharm Corp, Ordinary, US 'Other OTC' and Grey Market (MSLPD.PK, US Other OTC (Pink Sheets))

Závěr k 3.4.2024	Změna (%)	Změna (USD)	Objem obchodů (ks)
0,00	-99,92	0,00	15 000

After-hours03.04.2024 23:20:00

Poslední obchod	Nákup / Prodej	Změna (%)	Změna (USD)
0,00	- -	-99,92	0,00

R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

Akce

Nákup / prodej ve cvičném portfoliu

Přidat do oblíbených

Nákup / Prodej Patria Direct

Nastavit SMS / E-Mail alert

Analytický servis

Databanka historických dat

Poslední aktualizace: 25.04.2024

Popis společnosti

Business Summary: MusclePharm Corporation is a United States company. The Company has no operation nor generated any revenue.
Financial Summary: BRIEF: For the three months ended 31 March 2022, MusclePharm Corp revenues remained flat at $13.1M. Net loss totaled $6.3M vs. income of $94K. Revenues reflect United States (Country) segment increase of 33% to $12.3M. Net loss reflects Selling, general, and administrative increase from $1.3M to $2.8M (expense), Interest expense, related party increase from $135K to $313K (expense).

Poslední aktualizace: 25.04.2024

Management společnosti

Funkce	Jméno	Věk	Ve funkci od	Ve firmě od
Independent Chairman of the Supervisory Board	Michael Diekmann	69	07.05.2017	01.01.1998
Chairman of the Management Board, Chief Executive Officer	Oliver Bate	59	07.05.2015	01.01.2008
Vice Chairwoman of the Supervisory Board	Gabriele Burkhardt-Berg	63	01.09.2018	01.09.2018
Independent Vice Chairman of the Supervisory Board	Herbert Hainer	69	04.05.2022	04.05.2022
Member of the Management Board for Finance, Risk, Actuarial, Legal, Compliance	Claire-marie Coste-lepoutre	48	01.01.2024	01.01.2024
Member of the Management Board, Operations and Information Technology	Barbara Karuth-Zelle	55	01.01.2021	01.01.2021
Member of the Management Board, Insurance Western & Southern Europe, Allianz Direct, Allianz Partners	Sirma Boshnakova	52	01.01.2022	01.01.2022
Member of the Management Board, Responsible for Insurance German Speaking Countries and Central and Eastern Europe	Klaus - Peter Rohler	59	01.04.2020	01.04.2020
Member of the Management Board, Investment Management, Sustainability	Guenther Thallinger	52	01.01.2017	01.01.2017
Member of the Management Board, Global Insurance Lines and Anglo Markets, Reinsurance, Middle East, Africa	Christopher Townsend	55	01.01.2021	01.01.2021

Detail akcie MusclePharm Corp, Ordinary, US 'Other OTC' and Grey Market online

PX

DAX

CZK/€

CZK/$

AU

BRT

Top akcie